Ranolazine

In the US, Ranolazine (ranolazine systemic) is a member of the drug class antianginal agents and is used to treat Angina.

US matches:

• Ranolazine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01EB18

CAS registry number (Chemical Abstracts Service)

0095635-55-5

Chemical Formula

C24-H33-N3-O4

Molecular Weight

427

Therapeutic Categories

Treatment of coronary heart disease

Enzyme inhibitor

Chemical Names

(RS)-4-[2-Hydroxy-3-(2-methoxyphenoxy)propyl]-2',6'-dimethylpiperazin-1-acetanilid (IUPAC)

(±)-4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2',6'-xylidide (WHO)

1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-, (±)- (CAS)

Foreign Names

• Ranolazinum (Latin)
• Ranolazin (German)
• Ranolazine (French)
• Ranolazina (Spanish)

Generic Names

• Ranolazine (OS: USAN)
• (-)-Ranolazine (IS)
• CVT-303 (IS)
• KEG-1295 (IS)
• RAN D (IS)
• Ran4 (IS)
• RS-43285-003 (IS)
• Ranolazine hydrochloride (OS: USAN)
• Ranolazine dihydrochloride (IS)
• RS-43285 (IS: Syntex)

Brand Names

• Ranexa
  A. Menarini, United Kingdom; Berlin-Chemie, Germany; Menarini, Spain; Menarini, Ireland; Menarini, Luxembourg; Gilead, United States

International Drug Name Search

Glossary

CAS	Chemical Abstracts Service
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.